What is the best treatment for a 12-year-old child with travel sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Travel Sickness (Motion Sickness) in a 12-Year-Old Child

Scopolamine transdermal patch is the first-line medication for preventing motion sickness in a 12-year-old child, applied at least 4 hours before travel, with first-generation antihistamines (such as dimenhydrinate or diphenhydramine) as effective alternatives if scopolamine is not available or tolerated. 1, 2

Pharmacologic Treatment Algorithm

First-Line: Scopolamine Transdermal System

  • Apply one scopolamine 1 mg/3 days transdermal patch to a hairless area behind one ear at least 4 hours before the anticipated motion exposure 1, 2
  • The patch can remain in place for up to 3 days if continuous protection is needed 1
  • After applying the patch, the child must wash their hands thoroughly with soap and water immediately to prevent accidental eye contact with the medication 1
  • Critical safety consideration: The patch should not be cut, and only one patch should be worn at any time 1

Second-Line: First-Generation Antihistamines

  • First-generation antihistamines are effective for motion sickness prevention, though they cause sedation 2, 3
  • These medications must be taken before departure to be effective 3
  • Common options include dimenhydrinate or diphenhydramine (specific dosing should follow pediatric weight-based guidelines)

Medications That Do NOT Work

  • Nonsedating antihistamines are NOT effective for motion sickness prevention or treatment 2
  • Ondansetron is NOT effective for motion sickness 2
  • Ginger root is NOT effective for motion sickness 2

Behavioral Strategies (Should Be Combined with Medication)

  • Position the child in the most stable part of the vehicle: front seat of a car (if age-appropriate and safe), middle of a boat, or over the wing in an airplane 2
  • Have the child watch the true visual horizon rather than looking down at books, screens, or other objects 2
  • If possible, have the child lie down with eyes closed during travel 2
  • Tilt the head into turns when the vehicle changes direction 2
  • Minimize other sources of physical discomfort (hunger, heat, anxiety) 2

Important Caveats and Side Effects

Scopolamine Patch Warnings

  • Most common side effects: dry mouth, dizziness, blurred vision, drowsiness, and disorientation 1
  • Serious concern: If the patch contacts the eyes, it can cause temporary pupil dilation and severe blurred vision 1
  • After removing the patch, wash both hands and the skin behind the ear thoroughly with soap and water 1
  • Withdrawal symptoms can occur if the patch is used for several days then removed, including dizziness, nausea, vomiting, and confusion starting 24 hours or more after removal 1
  • The used patch still contains active medication and must be folded in half (sticky sides together) and disposed of in household trash out of reach of children and pets 1

When to Avoid Scopolamine

  • Do not use if the child has difficulties with stomach emptying, as this can worsen abdominal pain, nausea, or vomiting 1
  • Avoid if there are concerns about urinary retention or narrow-angle glaucoma (standard anticholinergic contraindications)

Practical Implementation

  • Early self-diagnosis is critical: Teach the child to recognize early symptoms (stomach awareness, malaise, drowsiness, irritability) that precede nausea 2
  • Timing is everything: The scopolamine patch must be applied at least 4 hours before travel, not after symptoms begin 1, 2
  • Gradual exposure helps: If possible, slow, intermittent exposure to motion can reduce symptoms over time 2
  • The effectiveness of all motion sickness medications is limited, so combining pharmacologic and behavioral strategies provides the best outcome 3

References

Research

Prevention and treatment of motion sickness.

American family physician, 2014

Research

[Motion sickness in motion: from carsickness to cybersickness].

Nederlands tijdschrift voor geneeskunde, 2018

Related Questions

How to treat motion sickness?
What medication is recommended for motion sickness in children?
What is the recommended treatment for motion sickness in a 6-year-old male?
What is the best medication for motion sickness?
What are the recommended medications for motion sickness in children?
Should a 6.5-week post-initiation obsessive-compulsive disorder (OCD) patient on escitalopram (selective serotonin reuptake inhibitor) continue with the current treatment plan?
What is the best alternative treatment for a patient with a history of pancreatitis who is currently taking Tresiba (insulin degludec) and metformin, and cannot take a GLP-1 (glucagon-like peptide-1) receptor agonist?
What is the likely diagnosis for a patient with macrocytic anemia, as indicated by elevated Hemoglobin and Hematocrit (H&H), Mean Corpuscular Volume (MCV), and Red Cell Distribution Width (RDW) values, possibly due to a nutritional deficiency such as vitamin B12 or folate deficiency?
Can N-acetylcysteine (NAC) be added to the treatment regimen of a 6.5-week post-initiation obsessive-compulsive disorder (OCD) patient on escitalopram (Selective Serotonin Reuptake Inhibitor - SSRI), and what is its efficacy in treating OCD?
What is the recommended gap between courses of phentermine use in a patient with a history of obesity and related comorbidities, such as hypertension, type 2 diabetes, or hypercholesterolemia?
What is the best course of treatment for a 66-year-old patient with impaired renal function (eGFR 96 mL/min/1.73m2), hypercalcemia (9.2 mg/dL), elevated alkaline phosphatase (168 IU/L), gallstones, adenomyomatosis, and renal lesions, including a 2.4 cm solid nodule on the left kidney and a 10 mm echogenic cortical lesion on the right kidney?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.